News Focus
News Focus
Followers 121
Posts 3371
Boards Moderated 0
Alias Born 06/28/2014

Re: alphapuppy post# 243620

Wednesday, 09/11/2019 12:40:14 AM

Wednesday, September 11, 2019 12:40:14 AM

Post# of 822579
Alphapuppy re:

Thanks Mav

I believe Guy at ASCO most resembled Roger Perlmutter.

Photonic also saw him. Hey photonic would you agree??

Alpha



Whoopee LIFT OFF is MORE THAN SET IMHO!!

I had to get current pics not via Google so that’s why I felt for multi prong purpose to use the pdf of 1st time in five years for Merck an Investor’s Day:

(I was thrown by your “middle age” description which felt more suitable seeing 40 yr old EVP Chief Marketing Officer.)

Roger Permutter is the Biggest Fish given that he left Merck for 11 years to build up AMGEN the world’s largest Biotech company in Thousand Oaks, CA just north of LA with great weather to return in the last 6 years to restructure Merck’s R&D portfolio Is the reason why Keytruda is the kingpin vs that of BMY’s Opdivo!

He graduated from Reed College and earned his MD and PhD from Washington University in St. Louis in 1979. He did his clinical training in internal medicine at Massachusetts General Hospital and University of California, San Francisco.[1] In 1981, he joined the Division of Biology at the California Institute of Technology before joining the University of Washington in 1984 to join the medicine and biochemistry department. In 1989, he was the founding chair of the immunology department. His research focused on the role of tyrosine kinase signaling and its role in lymphocyte development and immunology.[2] During that time he was also a Howard Hughes Medical Institute (HHMI) investigator.[3][4]

In 1997, Perlmutter joined Merck Research Laboratories as the executive vice president of basic and preclinical research. At the time, Perlmutter was not chosen to replace Edward Scolnik as President of Merck Research Laboratories; that position went instead to Peter S. Kim, previously of the Massachusetts Institute of Technology. In 2001, Perlmutter left Merck and joined Amgen as the executive vice president and head of R&D from January 2001 to February 2012. In 2013, he replaced Peter S. Kim as the executive vice president and president of Merck Research Laboratories.[5]

He was the president of the American Association of Immunologists and a fellow of the American Academy of Arts and Sciences and the American Association for the Advancement of Science. He also serves on the boards of the Institute for Systems Biology and StemCells Inc.[6]

https://en.m.wikipedia.org/wiki/Roger_M._Perlmutter

DIFFERENT STROKES FOR DIFFERENT FOLKS

ALWAYS GOING THE EXTRA MILE

DON’T PUT OFF TILL TOMORROW WHAT YOU CAN DO TODAY

BREADTH; DEPTH & RELEVANCE spanning 40 yrs of Investment Research producing RESULTS trump’s noise

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News